In a study, researchers investigated the possible role of TXNIP in type 1 diabetes-associated non-alcoholic fatty liver disease (NFALD) in the rat BRL-3A and human HepG2 cells. The gene discussed is TXNIP; the disease is metabolic dysfunction-associated steatotic liver disease.